![Scott Willoughby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 122 387 $ in data 31/05/2026
Scott Willoughby is currently Secretary & Chief Legal Officer at Sangamo Therapeutics, Inc. Formerly, Mr. Willoughby was Vice President-Deputy General Counsel & Head-Law at Achaogen, Inc. Mr. Willoughby completed undergraduate and graduate degrees at the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/05/2026 | 561.406 ( 0,14% ) | 122 387 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Consigliere Generale | 01/03/2020 |
| Società | Posizione | Fine |
|---|---|---|
| ACHAOGEN | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
